<?xml version='1.0' encoding='utf-8'?>
<document id="27575876"><sentence text="Atorvastatin attenuation of ABCB1 expression is mediated by microRNA miR-491-3p in Caco-2 cells."><entity charOffset="0-12" id="DDI-PubMed.27575876.s1.e0" text="Atorvastatin" /></sentence><sentence text="Atorvastatin, a HMG-CoA reductase inhibitor, used in the treatment of hypercholesterolemia, has been previously shown to regulate ABCB1 expression in vivo and in vitro"><entity charOffset="0-12" id="DDI-PubMed.27575876.s2.e0" text="Atorvastatin" /></sentence><sentence text=" We hypothesized that the statin could regulate gene expression of ABCB1 transporter via microRNAs" /><sentence text="" /><sentence text="Expression of microRNAs and ABCB1 mRNA was examined in atorvastatin-treated and control cells using real-time PCR"><entity charOffset="55-67" id="DDI-PubMed.27575876.s5.e0" text="atorvastatin" /></sentence><sentence text=" miR-491-3P mimic and inhibitor were transfected in Caco-2 and ABCB1 expression was monitored by western blot and real-time PCR" /><sentence text="" /><sentence text="In HepG2 cells, none of the microRNAs predicted to target ABCB1 3'UTR was regulated by atorvastatin treatment"><entity charOffset="87-99" id="DDI-PubMed.27575876.s8.e0" text="atorvastatin" /></sentence><sentence text=" In agreement with this, ABCB1 3'UTR activity was not modulated in HepG-2 cells after 48h-treatment as measured by luciferase assay" /><sentence text=" In Caco-2 cells, atorvastatin treatment provoked a decrease in luciferase activity and, accordingly, miR-491-3p was upregulated about 2"><entity charOffset="18-30" id="DDI-PubMed.27575876.s10.e0" text="atorvastatin" /></sentence><sentence text="7 times after 48h-statin treatment" /><sentence text=" Luciferase analysis of miR-491-3p with a mimetic or inhibitor of miR-491-3p revealed that this microRNA could target ABCB1 3'UTR, as after miR-491-3p inhibition, ABCB1 levels were increased by two-fold, and miR-491-3p superexpression decreased ABCB1 3'UTR activity" /><sentence text=" Finally, functional analysis revealed that treatment with miR-491-3p inhibitor could reverses atorvastatin attenuation of ABCB1 (Pg-p) protein levels"><entity charOffset="95-107" id="DDI-PubMed.27575876.s13.e0" text="atorvastatin" /></sentence><sentence text="" /><sentence text="Our results suggest atorvastatin control ABCB1 expression via miR-491-3p in Caco-2 cells"><entity charOffset="20-32" id="DDI-PubMed.27575876.s15.e0" text="atorvastatin" /></sentence><sentence text=" This finding may be an important mechanism of statin drug-drug interaction, since common concomitant drugs used in the prevention of cardiovascular diseases are ABCB1 substrates" /><sentence text="" /></document>